SAKL yields 25000.00% · PFE yields 6.13%● Live data
📍 SAKL pulled ahead of the other in Year 1
Combined, SAKL + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SAKL + PFE for your $10,000?
Sack Lunch Productions, Inc., together with its subsidiaries, engages in the event and film production businesses worldwide. The company operates through three segments: Events, Salons, and Other. The Events segment produces branded events under the Color Me Rad, The Dirty Dash, Lantern Fest, Slide the City, and Trike Riot trademarked names; and franchises its branded events to third parties under agreements with various franchisees. The Salons segment operates health and beauty salons. This segment operates through a network of two Aveda lifestyle salons; and an Aveda retail store. The Other segment distributes films; provides assisting services in the development and production of film products; and acquires, leases, and sells commercial and residential properties. The company was formerly known as Nexia Holdings, Inc. and changed its name to Sack Lunch Productions, Inc. in April 2015. Sack Lunch Productions, Inc. was incorporated in 1987 and is headquartered in Salt Lake City, Utah.
Full SAKL Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.